home / stock / labp / labp quote
Last: | $22.93 |
---|---|
Change Percent: | 0.0% |
Open: | $22.93 |
Close: | $22.93 |
High: | $22.94 |
Low: | $22.75 |
Volume: | 50,899 |
Last Trade Date Time: | 05/23/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$22.93 | $22.93 | $22.93 | $22.94 | $22.75 | 50,899 | 05-23-2024 |
$22.7971 | $22.36 | $22.7971 | $22.88 | $22.36 | 35,001 | 05-22-2024 |
$22.3 | $22.25 | $22.3 | $22.4 | $22.25 | 10,096 | 05-21-2024 |
$22.21 | $22.3 | $22.21 | $22.4552 | $22.2002 | 17,977 | 05-20-2024 |
$22.47 | $22.39 | $22.47 | $22.47 | $22.325 | 12,928 | 05-17-2024 |
$22.3 | $22.4 | $22.3 | $22.46 | $22.29 | 5,739 | 05-16-2024 |
$22.3 | $22.3495 | $22.3 | $22.45 | $22.3 | 12,273 | 05-15-2024 |
$22.45 | $22.48 | $22.45 | $22.58 | $22.25 | 2,386 | 05-14-2024 |
$22.205 | $22.41 | $22.205 | $22.42 | $22.13 | 3,896 | 05-13-2024 |
$22.33 | $22.13 | $22.33 | $22.375 | $22.13 | 10,749 | 05-10-2024 |
$22.36 | $22.1782 | $22.36 | $22.48 | $22.13 | 5,058 | 05-09-2024 |
$22.205 | $22.1459 | $22.205 | $22.2078 | $22.1201 | 5,249 | 05-08-2024 |
$22.17 | $22.18 | $22.17 | $22.2855 | $22.1201 | 7,834 | 05-07-2024 |
$22.15 | $22.1 | $22.15 | $22.195 | $22.02 | 6,357 | 05-06-2024 |
$22.235 | $22.2912 | $22.235 | $22.43 | $22.185 | 3,863 | 05-03-2024 |
$22.25 | $22.12 | $22.25 | $22.3624 | $21.91 | 6,316 | 05-02-2024 |
$22.2931 | $22.46 | $22.2931 | $22.46 | $22.15 | 9,671 | 05-01-2024 |
$22.3 | $22.46 | $22.3 | $22.46 | $22.18 | 1,677 | 04-30-2024 |
$22.4799 | $22.36 | $22.4799 | $22.49 | $22.2 | 3,969 | 04-29-2024 |
$22.31 | $22.35 | $22.31 | $22.5501 | $22.31 | 14,876 | 04-26-2024 |
News, Short Squeeze, Breakout and More Instantly...
Landos Biopharma Inc. Company Name:
LABP Stock Symbol:
NASDAQ Market:
Landos Biopharma Inc. Website:
2024-05-26 06:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
AbbVie Completes Acquisition of Landos Biopharma PR Newswire - Adds first-in-class investigational asset, NX-13, to AbbVie's pipeline with the potential to offer a novel approach to the treatment of ulcerative colitis (UC) and Crohn's disease (CD) NORTH CHICAGO, Ill....
2024-05-06 13:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...